A chance to overcome depression

The Relight clinical research study is currently testing an investigational medication for people living with depression, or Major Depressive Disorder (MDD).

Living with MDD

Even with treatment, depression may continue to be challenging. That is why researchers are exploring how an investigational medication, when added to existing antidepressants, may help manage MDD. If you are currently taking antidepressants but find that they are not fully managing your symptoms, participating in the Relight clinical research study may be an option for you.

Major depressive disorder (MDD) is one of the most common mental health conditions today

•

One in five people experience depression during their lifetime.

•

MDD is typically diagnosed when an individual experiences the following symptoms: feelings of sadness, difficulty sleeping, changes in appetite or weight, fatigue, low energy, guilt, or loss of joy in things that typically interest them.

•

People living with depression can often experience repeating periods of feeling depressed. On average, up to 50% of those who recover from a first episode of depression have one or more additional episodes in their lifetime.¹

The Relight clinical research study is enrolling now

By joining this research study, your participation may help change the future of how doctors treat MDD.

Find a study location

You may be eligible to participate as a volunteer if you:

Are 18-65 years of age

Have been diagnosed with depression (major depressive disorder)

Are currently feeling depressed and are taking an antidepressant

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169519/